Foghorn Therapeutics Inc (FHTX)
7.84
+0.12
(+1.55%)
USD |
NASDAQ |
Nov 22, 16:00
7.84
0.00 (0.00%)
After-Hours: 20:00
Foghorn Therapeutics Total Liabilities (Quarterly): 336.66M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 336.66M |
| June 30, 2024 | 342.91M |
| March 31, 2024 | 352.49M |
| December 31, 2023 | 363.11M |
| September 30, 2023 | 370.81M |
| June 30, 2023 | 388.93M |
| March 31, 2023 | 397.47M |
| December 31, 2022 | 404.77M |
| September 30, 2022 | 409.61M |
| June 30, 2022 | 409.27M |
| Date | Value |
|---|---|
| March 31, 2022 | 415.90M |
| December 31, 2021 | 422.90M |
| September 30, 2021 | 105.09M |
| June 30, 2021 | 104.34M |
| March 31, 2021 | 104.72M |
| December 31, 2020 | 109.41M |
| September 30, 2020 | 275.75M |
| June 30, 2020 | 76.20M |
| December 31, 2019 | 110.36M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
76.20M
Minimum
Jun 2020
422.90M
Maximum
Dec 2021
289.51M
Average
352.49M
Median
Mar 2024
Total Liabilities (Quarterly) Benchmarks
| Sana Biotechnology Inc | 266.91M |
| Omega Therapeutics Inc | 141.18M |
| Moderna Inc | 3.876B |
| United Therapeutics Corp | 1.022B |
| CEL-SCI Corp | 15.60M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 308.37M |
| Shareholders Equity (Quarterly) | -28.29M |
| Current Ratio | 4.773 |